Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
MAGE-A4ᶜ¹º³²T Therapy for Cancer
Recruiting1 awardPhase 1
Toronto, Ontario
This trial will study the safety of using T cells to attack cancer in patients who express the MAGE-A4 protein in their tumors. A subset of patients will also receive low-dose radiation therapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.